APF
MRNA icon

Alaska Permanent Fund’s Moderna MRNA Stock Holding History

Alaska Permanent Fund’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$3.31M Hold
18,400
– – 0.05% 107
2022
Q3 		$2.18M Hold
18,400
– – 0.04% 164
2022
Q2 		$2.63M Buy
18,400
+5,600
+44% +$800K 0.04% 104
2022
Q1 		$2.21M Hold
12,800
– – 0.04% 155
2021
Q4 		$2.17M Hold
12,800
– – 0.04% 176
2021
Q3 		$4.93M Hold
12,800
– – 0.1% 32
2021
Q2 		$3.01M Buy
+12,800
New +$2.29M 0.05% 33

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alaska Permanent Fund's MRNA Position: Q4 2022 in Review

Alaska Permanent Fund held its Moderna (MRNA) position steady in Q4 2022 at 18,400 shares worth $3.31M. The position accounts for 0.05% of the portfolio, ranked #107.

Alaska Permanent Fund first reported a position in MRNA in Q2 2021 and has held it in 7 quarters since. The position peaked at $4.93M in Q3 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Alaska Permanent Fund held 18,400 shares of Moderna worth $3.31M as of Q4 2022.
  • Alaska Permanent Fund left its Moderna share count unchanged in Q4 2022.
  • Moderna made up 0.05% of Alaska Permanent Fund's portfolio in Q4 2022, its #107 holding.
  • Alaska Permanent Fund first reported a position in Moderna in Q2 2021 and has held it in 7 quarters since.
  • Alaska Permanent Fund's Moderna position peaked at $4.93M in Q3 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Alaska Permanent Fund's 13F filing for Q4 2022, filed 8 Feb 2023.